01 1Hubei Haosun Pharmaceutical Co., Ltd.
01 1DASATINIB ANHYDROUS
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2020-12-01
Pay. Date : 2020-06-18
DMF Number : 34875
Submission : 2020-05-31
Status : Active
Type : II
20
Hubei Haosun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is DASATINIB ANHYDROUS, with a corresponding US DMF Number 34875.
Remarkably, this DMF maintains an Active status since its submission on May 31, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 01, 2020, and payment made on June 18, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
